Booz Allen Hamilton Holding Corporation · BAH · FY2027 Q2 · Calendar Q4 2026
Booz Allen pairs modest revenue decline with stronger defense-tech focus
The current analysis supports a constructive but qualified outlook: resilient national-security demand, cyber and defense-tech expansion, and a large backlog provide support, while modest revenue decline, civil weakness, and federal funding uncertainty temper the case for sustained growth.
Research this report with FN2. Free to start; review your question before sending.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about BAH FY2027 Q2
Choose a question to continue your researchFree to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
Relative to the prior quarter, the company highlighted the launch of Velox and Guile, completed the Ultra I&C Mission Solutions acquisition, and described a stronger defense-tech product focus. The current analysis also reports FY27 adjusted EBITDA and EPS guidance with a higher lower end, while revenue growth expectations remain modest.
Guidance delta
Management maintained FY27 revenue guidance and raised the lower end of adjusted EBITDA and EPS guidance, according to the current transcript analysis.
Key takeaways
- Revenue declined modestly, while ex-billable performance and national-security growth remained stronger.
- Management identified cyber, defense technology, Velox, Guile, and the Ultra acquisition as key growth drivers.
- A $41 billion backlog, including $5.7 billion funded, supports the outlook, but federal budget uncertainty remains.
- Management expects outcome-based and fixed-price contracting to improve margins over time.
Management priorities
- Scale and commercialize the Velox Agentic Cyber suite and Guile counter-SI product.
- Integrate Ultra I&C Mission Solutions into the defense-technology business.
- Continue investment in SI, quantum, 6G, and other emerging technology platforms.
- Expand outcome-based contracting while maintaining disciplined capital deployment.
Follow BAH with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Neutral | Neutral | Maintain | Nov 10, 2026 |
| TD Cowen | Buy | Hold | Upgrade | Oct 26, 2026 |
| BNP Paribas | Neutral | Neutral | Maintain | Oct 26, 2026 |
| Truist Securities | Buy | Hold | Upgrade | Oct 8, 2026 |
| Jefferies | Hold | Hold | Maintain | Oct 7, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 27, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 23, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Jul 20, 2026 |
| Goldman Sachs | Sell | Sell | Maintain | Jul 14, 2026 |
| Stifel | Buy | Hold | Upgrade | May 26, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | May 26, 2026 |
| William Blair | Outperform | Market Perform | Upgrade | Jul 22, 2025 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 28, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | May 27, 2025 |
| Raymond James | Outperform | Market Perform | Upgrade | Feb 3, 2025 |
| Morgan Stanley | Overweight | Overweight | Maintain | Feb 2, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Oct 31, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 2, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Apr 14, 2020 |
| Vertical Research | Hold | Buy | Downgrade | Jul 9, 2018 |
| Bank of America | Neutral | Neutral | Maintain | Jun 8, 2018 |
| Drexel Hamilton | Hold | Buy | Downgrade | Jun 16, 2017 |
| Stifel Nicolaus | Buy | Buy | Maintain | Nov 26, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $81.02. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $86 | $82.3 | +6.1% | Oct 26, 2026 |
| TD Cowen | Gautam Khanna | $95 | $83.36 | +17.3% | Oct 26, 2026 |
| National Bank | Analyst unavailable | $95 | $78.32 | +17.3% | Oct 26, 2026 |
| Bank of America Securities | Analyst unavailable | $68 | $78.32 | -16.1% | Oct 26, 2026 |
| Truist Financial | Tobey Sommer | $85 | $68.69 | +4.9% | Oct 8, 2026 |
| Jefferies | Sheila Kahyaoglu | $75 | $67.24 | -7.4% | Oct 7, 2026 |
| Jefferies | Analyst unavailable | $80 | $75.65 | -1.3% | Sep 1, 2026 |
| UBS | Gavin Parsons | $78 | $72.35 | -3.7% | Jul 27, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $140 | $66.13 | +72.8% | Jul 23, 2026 |
| Goldman Sachs | Noah Poponak | $65 | $64.8 | -19.8% | Jul 14, 2026 |
| Truist Financial | Analyst unavailable | $70 | $63.41 | -13.6% | Jul 10, 2026 |
| BNP Paribas | Analyst unavailable | $80 | $80.26 | -1.3% | May 27, 2026 |
| UBS | Gavin Parsons | $83 | $79 | +2.4% | May 26, 2026 |
| Stifel Nicolaus | Analyst unavailable | $110 | $78.68 | +35.8% | May 26, 2026 |
| Jefferies | Analyst unavailable | $85 | $74.95 | +4.9% | May 11, 2026 |
| UBS | Analyst unavailable | $97 | $92.84 | +19.7% | Jan 27, 2026 |
| D.A. Davidson | Jeff Rulis | $81 | $92.75 | -0.0% | Jan 27, 2026 |
| Stifel Nicolaus | Analyst unavailable | $115 | $102.23 | +41.9% | Jan 26, 2026 |
| Truist Financial | Analyst unavailable | $98 | $102.23 | +21.0% | Jan 23, 2026 |
| Jefferies | Q3 EPS | $95 | $86.85 | +17.3% | Dec 18, 2025 |
| UBS | Analyst unavailable | $93 | $90.22 | +14.8% | Oct 27, 2025 |
| Goldman Sachs | Noah Poponak | $80 | $91.4 | -1.3% | Oct 27, 2025 |
| Stifel Nicolaus | Analyst unavailable | $106 | $91.4 | +30.8% | Oct 24, 2025 |
| Truist Financial | Tobey Sommer | $90 | $91.4 | +11.1% | Oct 24, 2025 |
| UBS | Gavin Parsons | $119 | $109.44 | +46.9% | Jul 28, 2025 |
| Stifel Nicolaus | Jonathan Siegmann | $119 | $109.38 | +46.9% | Jul 28, 2025 |
| UBS | Gavin Parsons | $159 | $148.18 | +96.2% | Dec 2, 2024 |
| Jefferies | Sheila Kahyaoglu | $190 | $182.62 | +134.5% | Nov 4, 2024 |
| Truist Financial | Tobey Sommer | $165 | $156.44 | +103.7% | Sep 5, 2024 |
| Wells Fargo | Matthew Akers | $165 | $139.84 | +103.7% | Jul 29, 2024 |
| Goldman Sachs | Gavin Parsons | $174 | $139.84 | +114.8% | Jul 26, 2024 |
| Truist Financial | Tobey Sommer | $140 | $139.84 | +72.8% | Jul 26, 2024 |
| CFRA | Caydee Blankenship | $160 | $139.84 | +97.5% | Jul 26, 2024 |
| Jefferies | Sheila Kahyaoglu | $185 | $154.6 | +128.3% | May 29, 2024 |
| Wells Fargo | Matthew Akers | $169 | $158.51 | +108.6% | May 28, 2024 |
| Truist Financial | Tobey Sommer | $160 | $158.51 | +97.5% | May 24, 2024 |
| Truist Financial | Tobey Sommer | $145 | $152.36 | +79.0% | May 24, 2024 |
| Jefferies | Sheila Kahyaoglu | $180 | $148.7 | +122.2% | May 14, 2024 |
| Truist Financial | Tobey Sommer | $120 | $120.45 | +48.1% | Jul 31, 2023 |
| Stifel Nicolaus | Bert Subin | $125 | $112.79 | +54.3% | Jul 13, 2023 |
| Morgan Stanley | Matthew Sharpe | $116 | $89.85 | +43.2% | May 26, 2023 |
| Morgan Stanley | Analyst unavailable | $118 | $104.58 | +45.6% | Jan 3, 2023 |
| Morgan Stanley | Analyst unavailable | $110 | $105.32 | +35.8% | Dec 14, 2022 |
| Raymond James | Brian Gesuale | $96 | $84.76 | +18.5% | May 25, 2022 |
| Goldman Sachs | Gavin Parsons | $102 | $87.01 | +25.9% | Apr 19, 2022 |
| Stifel Nicolaus | Bert Subin | $96 | $86.68 | +18.5% | Mar 20, 2022 |
| Bank of America Securities | Ronald Epstein | $90 | $83.49 | +11.1% | Mar 14, 2022 |
| Barclays | David Strauss | $105 | $75.25 | +29.6% | Jan 30, 2022 |
| Morgan Stanley | Matthew Sharpe CFA | $98 | $86.92 | +21.0% | Nov 2, 2021 |
Track every rating change on BAH the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationBooz Allen Hamilton Holding Corporation (BAH) operates as a prominent consulting and technology firm, offering a diverse range of services to governmental bodies, commercial enterprises, and non-profit organizations both domestically and internationally. Their core offerings encompass strategic management and technology advisory, with a focus on areas like business strategy, human resources, and operational efficiency across various sectors. A significant aspect of their work involves advanced analytics.…
Historical context
All BAH earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FRO Frontline Plc | FY2026 Q3 · Calendar Q4 2026 | -11.5% | +1.0% | Frontline posts record Q3 profit as spot tanker rates surge |
| WWD Woodward, Inc. | FY2026 Q4 · Calendar Q4 2026 | +11.4% | +6.9% | Woodward reports record FY2026 results and outlines growth priorities for 2027 |
| ZTO ZTO Express (Cayman) Inc. | FY2026 Q3 · Calendar Q4 2026 | +2.9% | -0.7% | Volume and retail-parcel growth support profit gains, with guidance cautious |
| ESLT Elbit Systems Ltd. | FY2026 Q3 · Calendar Q4 2026 | +1.4% | +5.8% | Elbit’s record backlog supports raised 2027 growth outlook, with execution risks |
| ACM Aecom | FY2026 Q4 · Calendar Q4 2026 | — | +11.1% | AECOM closes FY2026 with record backlog and margin; FY2027 outlook maintained |
| ARMK Aramark | FY2026 Q4 · Calendar Q4 2026 | -6.0% | +2.7% | Aramark Posts Record FY2026, Targets 9–10% Organic Growth in FY2027 |
Latest beats and misses
Who reports nextBeat on EPS
- BJFY2026 Q3 · November 20, 2026+37.3% EPS-5.4% move
- INTUFY2027 Q1 · November 19, 2026+18.3% EPS-6.2% move
- ROSTFY2026 Q3 · November 19, 2026+2.1% EPS-2.8% move
- ESTCFY2027 Q2 · November 19, 2026+16.2% EPS+2.0% move
- KEYSFY2026 Q4 · November 19, 2026+7.1% EPS-1.5% move
- WSMFY2026 Q3 · November 19, 20260.0% EPS-15.2% move
Missed on EPS
- FROFY2026 Q3 · November 20, 2026-11.5% EPS+1.0% move
- NTESFY2026 Q3 · November 19, 2026-12.8% EPS-11.4% move
- FUTUFY2026 Q3 · November 19, 2026-7.8% EPS+4.8% move
- BABAFY2027 Q2 · November 19, 2026-29.2% EPS-1.3% move
- SQMFY2026 Q3 · November 17, 2026-3.0% EPS-5.5% move
- VIKFY2026 Q3 · November 17, 2026-12.6% EPS+4.4% move
Get the BAH recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-23T15:03:39.210998+00:00
- FN2 earnings calendar · 2026-10-27T01:23:15.065758+00:00
- Polygon adjusted daily market bars · 2026-10-27T01:30:41.875324+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-27T01:30:41.872434+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-27. For educational purposes only; not investment advice.